SanaClis, a global full-service CRO with an integrated clinical supply chain, has officially acquired S2 ScienceSolutions, an owner-managed contract research organisation based in Vienna, Austria. The ...

Vaccine and biotech stocks plunged after a top regulator left the US Food and Drug Administration, casting deep uncertainty about the future of vaccines and cutting-edge gene therapies. Peter Marks, a ...

However, the rotavirus vaccine (RV) is given by mouth through liquid drops. Diphtheria, Tetanus, Acellular Pertussis (DTaP) The DTaP vaccination is given in five doses. The first dose begins at 2 ...

In GSK’s suit against Pfizer, the British pharma was seeking monetary damages or royalties and potentially a permanent injunction on the commercialization of Pfizer’s RSV vaccine in the U.S.

(Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violated GSK's patent ...

and GSK’s Penmenvy (meningococcal groups A, B, C, W, and Y Vaccine), a newly approved 5-in-1 meningococcal vaccine. 1,2 ACIP voted to broaden its recommendation for RSV vaccines such as Abrysvo to ...

The ACIP has now recommended the use of GSK’s RSV vaccine, Arexvy, and PFE’s RSV vaccine, Abrysvo, in adults aged 50-59 who are at high risk of severe RSV disease. Individuals with underlying ...

April 3 (Reuters) - British pharmaceutical giant GlaxoSmithKline (GSK.L), opens new tab and rival Pfizer (PFE.N), opens new tab have agreed to end a lawsuit that alleged Pfizer's respiratory ...

A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...

CDC panel expands Pfizer and GSK RSV vaccine use to high-risk adults 50–59, building on earlier recommendations for older ...

Genital herpes is an infection of the genitals, buttocks, or anal area caused by herpes simplex virus (HSV).

However, the ability of inactivated vaccine-induced antibodies to neutralize both SARS-CoV-2 and its Omicron variant following a third SARS-CoV-2 vaccine dose remains unclear in these patients.